Evolus
EOLS
#7863
Rank
โ‚น38.02 B
Marketcap
โ‚น577.43
Share price
-0.17%
Change (1 day)
-29.92%
Change (1 year)

Revenue for Evolus (EOLS)

Revenue in 2026 (TTM): โ‚น27.01 Billion

According to Evolus 's latest financial reports the company's current revenue (TTM ) is โ‚น29.14 Billion. In 2025 the company made a revenue of โ‚น26.67 Billion an increase over the revenue in the year 2024 that were of โ‚น22.84 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Evolus from 2017 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น27.01 B1.28%
2025 โ‚น26.67 B16.79%
2024 โ‚น22.84 B35.78%
2023 โ‚น16.82 B36.8%
2022 โ‚น12.29 B65.77%
2021 โ‚น7.41 B79.41%
2020 โ‚น4.13 B66.03%
2019 โ‚น2.49 B
2018 N/A
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA